Monkeypox mAb Program

About Adnexus

Adnexus is a private, pre-revenue biotech company pioneering an AI-driven approach to monoclonal antibody discovery against infectious diseases. Its core technology, the Sutra™ platform, analyzes viral targets to identify immutable epitopes and facilitates rapid antibody generation from human B-cells of recovered patients. The company has demonstrated proof-of-concept by identifying conserved targets for HIV, SARS-CoV-2, and Monkeypox, positioning itself in the high-need market for broad-spectrum antiviral therapeutics.

Therapeutic Areas